Literature DB >> 12140373

Imaging techniques for evaluation of the uterine cavity and endometrium in premenopausal patients before minimally invasive surgery.

Margit Dueholm1, Erik Lundorf, Frede Olesen.   

Abstract

UNLABELLED: A literature review compared the diagnostic effectiveness and accuracy of transvaginal sonography (TVS) hysterosonographic examination (HSE), hysteroscopy (HY), and magnetic resonance imaging (MRI) in abnormalities of the uterine cavity and endometrium in premenopausal patients referred to surgery and women with abnormal uterine bleeding. The studies varied much in terms of patient selection, number of observers, blinding and experience of observers, and definition of abnormality criteria. The diagnostic effectiveness of the techniques reviewed varied: TVS only reached intermediate quality levels as a diagnostic tool for exclusion of uterine cavity abnormalities and no data support that MRI, TVS, HY, or HSE may exclude hyperplasia without concomitant endometrial sampling. HY and HSE were equally effective and apparently outperformed TVS, especially for identification of polyps. However, all techniques carried a significant number of false positive results. MRI does not satisfy current diagnostic demands for detection of endometrial abnormalities, but it is sufficiently accurate for submucous myoma (SM) evaluation. TVS, HSE, and HY carry much observer variation as opposed to MRI. In experienced hands TVS should be a first choice modality, but its precision and consistency fall short of current needs and it should therefore be supplemented by other techniques. HSE or HY performed by experienced clinicians should be used as supplements to TVS for exclusion of polyps. MRI can be recommended as the first choice modality for exact evaluation of SM uterine in-growth before advanced minimal invasive treatment of myomas. Clinicians should be aware that modern imaging techniques may yield highly idiosyncratic results when used by inexperienced staff, and efforts should be made to reduce such observer variation. TARGET AUDIENCE: Obstetricians & Gynecologists, Family Physicians. LEARNING
OBJECTIVES: After completion of this article, the reader will be able to describe the diagnostic strengths and weaknesses of the various diagnostic tests in the evaluation of abnormal uterine bleeding and to compare the accuracy of each test to the others.

Entities:  

Mesh:

Year:  2002        PMID: 12140373     DOI: 10.1097/01.OGX.0000019202.67816.3F

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  5 in total

1.  A novel saline infusion sonohysterography-based strain imaging approach for evaluation of uterine abnormalities in vivo: preliminary results.

Authors:  Eenas A Omari; Tomy Varghese; Mark A Kliewer
Journal:  J Ultrasound Med       Date:  2012-04       Impact factor: 2.153

2.  Exvivo ultrasound attenuation coefficient for human cervical and uterine tissue from 5 to 10 MHz.

Authors:  Miklos Z Kiss; Tomy Varghese; M A Kliewer
Journal:  Ultrasonics       Date:  2010-11-27       Impact factor: 2.890

3.  Comparison of transvaginal sonography and saline contrast sonohysterography in women with abnormal uterine bleeding: correlation with hysteroscopy and histopathology.

Authors:  Muhammad Aslam; Lubna Ijaz; Shamsa Tariq; Kausar Shafqat; Rubina Ashraf; Tahira Kazmi
Journal:  Int J Health Sci (Qassim)       Date:  2007-01

4.  Uterine artery embolization technique for treatment of a huge multi myomatous uterus in a virgin woman.

Authors:  Masoumeh Ghafarzadeh; Saeid Marzban-Rad; Parastesh Sattari; Hamid Reza Taheri
Journal:  Ann Med Surg (Lond)       Date:  2022-05-03

5.  Accuracy of transvaginal ultrasonography compared to endometrial biopsy for the etiological diagnosis of abnormal perimenopausal bleeding.

Authors:  Renata Nicula; Doru Diculescu; Codruţa Claudia Lencu; Răzvan Ciortea; Carmen Elena Bucuri; Ioana Adriana Oltean; Ioana Alexandra Trif; Dan Mihu
Journal:  Clujul Med       Date:  2017-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.